Skip to main content
Category

Full Member

Bertrand Desmets
In Full Member, M

Miltenyi Biotec

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, and cancer. Currently, Miltenyi Biotec has more than 4,700 employees in 23 countries. Empowering discovery. Advancing therapy….

Read More
Bertrand Desmets
In Full Member, H

Hyline

As a clean process contractor, Hyline improves your production process in terms of quality, efficiency and flow, from engineering, project supervision and installation, through to validation and maintenance. Hyline is the Eiffage Energie Systèmes brand standing out as a process integrator and specialist in orbital welding and specializing in a...
Read More
Bertrand Desmets
In Full Member, I

iol Strategic Design

iol Strategic Design is a design research and development company with over 25 years of experience in designing products. We guide customers from the innovation quest to the development of functional prototypes. Innovating in healthcare with human centred design iol supports studies from concept to production with the internal support...
Read More
Bertrand Desmets
In Full Member, G

Genflow Biosciences

Founded in 2020, Genflow conducts its R&D in Belgium at the BioPark, Gosselies. Genflow is one of the few European listed companies focused on longevity biotech discovery to increase human life spans with better health. It was listed on the London Stock Exchange (GENF) in January 2022.  In 2023, Genflow...
Read More
Bertrand Desmets
In Full Member, K

Kedroz srl

Kedroz Srl is developing the first European multi-pathological digital social network: Stent.care. Kedroz distinguishes itself through its ethical management of self-reported health data (PROMs and PREMs) by offering a GDPR-compliant secure space for the exchange of information between patients and healthcare professionals, the development of clinical and marketing studies (surveys),…

Read More
Bertrand Desmets
In A, Full Member

AbolerIS Pharma

Founded in 2019 by 3 prestigious scientists, AbolerIS Pharma is a Belgian biopharmaceutical company developing a novel approach to the treatment of chronic autoimmune and inflammatory diseases. The AbolerIS team is composed of scientific founders with decades of experience in basic and translational immunology and a strong leadership team with…

Read More
Bertrand Desmets
In Full Member, L

LiveDrop

LiveDrop is developing instruments for cellular analysis for biotechnologies. The application areas are vast, ranging from fundamental research in immunology-oncology to the discovery of therapeutic antibodies and cell therapy. Unlock the potential of your cells We develop innovative integrated instruments for high-throughput single-cell functional screening (including co-culture and potency assay),...
Read More
Bertrand Desmets
In B, Full Member

BioLizard

BioLizard is a leading multinational bioinformatics, data analytics, and data management service and consulting company heading digital transformation in the life sciences industry. Headquartered in Ghent, Belgium, BioLizard is the trusted go-to partner for data strategy and execution for life science companies engaged in activities ranging from drug discovery to...
Read More
Bertrand Desmets
In C, Full Member

Q1 Scientific – a Cambrex company

If you are looking for a secure, reliable and cost-effective way to store your pharmaceutical and medical device products under any ICH or custom temperature and humidity condition, you need Q1 Scientific, the leader in outsourced stability storage. Operating from state-of-the-art facilities in Belgium and Ireland, Q1 Scientific helps improve...
Read More
Bertrand Desmets
In C, Full Member

convEyXO

Therapeutic portfolio development for the treatment of chronic inflammation based on exosomes enriched with active substances by mechanoporation and produced on a large scale using a new-generation technology on a 3D matrix in fixed-bed bioreactors. ConvEyXo, a preclinical-stage biotech, aims to revolutionise access to exosome-based treatments through innovative technology platforms….

Read More